AU2019326462C1 - Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus - Google Patents

Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Info

Publication number
AU2019326462C1
AU2019326462C1 AU2019326462A AU2019326462A AU2019326462C1 AU 2019326462 C1 AU2019326462 C1 AU 2019326462C1 AU 2019326462 A AU2019326462 A AU 2019326462A AU 2019326462 A AU2019326462 A AU 2019326462A AU 2019326462 C1 AU2019326462 C1 AU 2019326462C1
Authority
AU
Australia
Prior art keywords
seq
oligomer
cmv
amplification
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019326462A
Other languages
English (en)
Other versions
AU2019326462B2 (en
AU2019326462A1 (en
Inventor
Paul Darby
Amber HILLIUS
Jo Ann Jackson
Hee Cheol Kim
Siobhan Miick
Ankur Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gen Probe Inc
Original Assignee
Gen Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Probe Inc filed Critical Gen Probe Inc
Publication of AU2019326462A1 publication Critical patent/AU2019326462A1/en
Publication of AU2019326462B2 publication Critical patent/AU2019326462B2/en
Priority to AU2026200796A priority Critical patent/AU2026200796A1/en
Application granted granted Critical
Publication of AU2019326462C1 publication Critical patent/AU2019326462C1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2019326462A 2018-08-21 2019-08-21 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus Active AU2019326462C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2026200796A AU2026200796A1 (en) 2018-08-21 2026-02-04 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862720658P 2018-08-21 2018-08-21
US62/720,658 2018-08-21
PCT/US2019/047419 WO2020041414A1 (en) 2018-08-21 2019-08-21 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2026200796A Division AU2026200796A1 (en) 2018-08-21 2026-02-04 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Publications (3)

Publication Number Publication Date
AU2019326462A1 AU2019326462A1 (en) 2021-03-25
AU2019326462B2 AU2019326462B2 (en) 2025-11-27
AU2019326462C1 true AU2019326462C1 (en) 2026-02-12

Family

ID=67874523

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019326462A Active AU2019326462C1 (en) 2018-08-21 2019-08-21 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus
AU2026200796A Pending AU2026200796A1 (en) 2018-08-21 2026-02-04 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2026200796A Pending AU2026200796A1 (en) 2018-08-21 2026-02-04 Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus

Country Status (6)

Country Link
US (1) US12454728B2 (https=)
EP (1) EP3841224A1 (https=)
JP (3) JP7579779B2 (https=)
AU (2) AU2019326462C1 (https=)
CA (1) CA3107043A1 (https=)
WO (1) WO2020041414A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000007357A1 (it) * 2020-04-07 2021-10-07 Elitechgroup S P A Metodo per il rilevamento e la quantificazione di citomegalovirus umano attraverso RNA virionici.

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036369A1 (en) * 2012-08-30 2014-03-06 Gen-Probe Incorporated Multiphase nucleic acid amplification

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422956A1 (fr) 1978-04-13 1979-11-09 Pasteur Institut Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
US4786600A (en) 1984-05-25 1988-11-22 The Trustees Of Columbia University In The City Of New York Autocatalytic replication of recombinant RNA
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4868105A (en) 1985-12-11 1989-09-19 Chiron Corporation Solution phase nucleic acid sandwich assay
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
ATE88762T1 (de) 1986-08-11 1993-05-15 Siska Diagnostics Inc Methoden und zusammensetzungen fuer tests mit nukleinsaeuresonden.
US5541308A (en) 1986-11-24 1996-07-30 Gen-Probe Incorporated Nucleic acid probes for detection and/or quantitation of non-viral organisms
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
US5283174A (en) 1987-09-21 1994-02-01 Gen-Probe, Incorporated Homogenous protection assay
US5639604A (en) 1987-09-21 1997-06-17 Gen-Probe Incorporated Homogeneous protection assay
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
ATE220796T1 (de) 1987-09-21 2002-08-15 Gen Probe Inc Schutztest
US5185439A (en) 1987-10-05 1993-02-09 Gen-Probe Incorporated Acridinium ester labelling and purification of nucleotide probes
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
US5130238A (en) 1988-06-24 1992-07-14 Cangene Corporation Enhanced nucleic acid amplification process
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5656207A (en) 1989-06-24 1997-08-12 Gen Probe Incorporated Detecting or quantifying multiple analytes using labelling techniques
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5849481A (en) 1990-07-27 1998-12-15 Chiron Corporation Nucleic acid hybridization assays employing large comb-type branched polynucleotides
US5378825A (en) 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
KR940703846A (ko) 1991-12-24 1994-12-12 비. 린네 파샬 갭(gap)이 형성된 2′ 변성된 올리고뉴클레오티드(gapped 2′ modifed oligonucleotides)
US5424413A (en) 1992-01-22 1995-06-13 Gen-Probe Incorporated Branched nucleic acid probes
JP4137996B2 (ja) 1992-05-06 2008-08-20 ジェン−プローブ・インコーポレイテッド 核酸配列増幅方法，組成物及びキット
CA2141430C (en) 1992-08-04 2009-05-12 Sherrol H. Mcdonough Nucleic acid sequence amplification
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
WO1995003430A1 (en) 1993-07-23 1995-02-02 Gen-Probe Incorporated Methods for enhancing nucleic acid amplification
US5925517A (en) 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US6169169B1 (en) 1994-05-19 2001-01-02 Dako A/S PNA probes for detection of Neisseria gonorrhoeae and Chlamydia trachomatis
EP0709466B1 (en) 1994-10-28 2006-09-27 Gen-Probe Incorporated Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences
US5731148A (en) 1995-06-07 1998-03-24 Gen-Probe Incorporated Adduct protection assay
EP0892808B1 (en) 1996-04-12 2008-05-14 PHRI Properties, Inc. Detection probes, kits and assays
US6534273B2 (en) 1997-05-02 2003-03-18 Gen-Probe Incorporated Two-step hybridization and capture of a polynucleotide
DE69836012T2 (de) 1997-05-02 2007-04-05 Gen-Probe Inc., San Diego Zwei-schritt hybridisierung und einfang von einem polynukleotid
US6180340B1 (en) 1997-10-31 2001-01-30 Gen-Probe Incorporated Extended dynamic range assays
ES2330812T3 (es) 1998-07-02 2009-12-15 Gen-Probe Incorporated Antorchas moleculares.
WO2006007567A2 (en) 2004-07-01 2006-01-19 Gen-Probe Incorporated Methods and compositions to detect nucleic acids in a biological sample
WO2006017724A1 (en) * 2004-08-06 2006-02-16 Becton, Dickinson And Company Sequences and methods for detection of cytomegalovirus
CA2898814C (en) 2004-08-27 2015-12-29 Gen-Probe Incorporated Single-primer nucleic acid amplification methods
CA2599013A1 (en) 2005-02-28 2006-09-08 Gen-Probe Incorporated Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe
US9051601B2 (en) 2006-08-01 2015-06-09 Gen-Probe Incorporated Methods of nonspecific target capture of nucleic acids
JP6150795B2 (ja) 2011-07-15 2017-06-28 ジェン−プロウブ インコーポレイテッド シングルプレックス又はマルチプレックスアッセイにおいてヒトパルボウイルス核酸を検出及びａ型肝炎ウイルス核酸を検出するための組成物及び方法
US20140193802A1 (en) * 2012-07-11 2014-07-10 Aicuris Gmbh & Co. Kg Identification of an altered therapeutic susceptibility to anti-hcmv compounds and of a resistance against anti-hcmv compounds
CN106591496B (zh) * 2017-01-19 2021-04-02 温州医科大学 一种涵盖全基因组的人巨细胞病毒基因pcr检测芯片

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036369A1 (en) * 2012-08-30 2014-03-06 Gen-Probe Incorporated Multiphase nucleic acid amplification

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LISA R. KEYES: "Characterization of the HCMV protein LUNA, and the cellular protein CyPA during latency/reactivation", 31 May 2011 (2011-05-31), XP055630019, Retrieved from the Internet <URL:https://scholarworks.unr.edu/bitstream/handle/11714/3815/Keyes_unr_0139D_10671.pdf?sequence=1&isAllowed=y> [retrieved on 20191008] *

Also Published As

Publication number Publication date
JP2021534758A (ja) 2021-12-16
AU2019326462B2 (en) 2025-11-27
JP2024116383A (ja) 2024-08-27
AU2019326462A1 (en) 2021-03-25
JP7579779B2 (ja) 2024-11-08
US12454728B2 (en) 2025-10-28
AU2026200796A1 (en) 2026-02-26
JP7770472B2 (ja) 2025-11-14
WO2020041414A1 (en) 2020-02-27
JP2025176114A (ja) 2025-12-03
US20220074002A1 (en) 2022-03-10
CA3107043A1 (en) 2020-02-27
EP3841224A1 (en) 2021-06-30

Similar Documents

Publication Publication Date Title
AU2026200796A1 (en) Compositions and methods for amplifying, detecting or quantifying human cytomegalovirus
US20220389485A1 (en) Compositions and methods for detecting group b streptococcus nucleic acid
AU2025271418B2 (en) Compositions and methods for detecting or quantifying Parainfluenza virus
JP7716995B2 (ja) 試料中のＴｒｉｃｈｏｍｏｎａｓ ｖａｇｉｎａｌｉｓの存在を決定する際に使用するためのオリゴヌクレオチド
US20250146090A1 (en) Compositions and Methods for Detecting Nucleic Acids of Epstein-Barr Virus
JP7542546B2 (ja) ヒトポリオーマウイルスｂｋウイルスを増幅、検出または定量化するための組成物および方法
WO2020197987A1 (en) Compositions and methods for detecting group a streptococcus
HK40061291A (en) Oligonucleotides for use in determining the presence of trichomonas vaginalis in a sample

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 13 NOV 2025

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 13 NOV 2025

FGA Letters patent sealed or granted (standard patent)